<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120635</url>
  </required_header>
  <id_info>
    <org_study_id>21-000697</org_study_id>
    <nct_id>NCT05120635</nct_id>
  </id_info>
  <brief_title>Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans</brief_title>
  <official_title>Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Greater Los Angeles Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>NeuroPace</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety&#xD;
      disorder (GAD) affect a large number of individuals with a significant portion of patients&#xD;
      failing to improve with current treatments.&#xD;
&#xD;
      The purpose of this study is to understand the brain mechanisms that produce fear and anxiety&#xD;
      in humans. To accomplish this goal, we will measure the brain activity along with the heart&#xD;
      rate and skin perspiration of patients while they are completing tasks on a computer. Some of&#xD;
      the tasks will also use a virtual reality headset and transport the patient in a video&#xD;
      game-like environment. These tasks will expose the participants to various levels of&#xD;
      fear-provoking images.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physiological change - eye-blinks</measure>
    <time_frame>during the intervention/behavioral tasks with and without stimulation</time_frame>
    <description>Eye blinks will be measured using an eye tracking device and will be measure in blinks per second.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physiological change - heart rate variability</measure>
    <time_frame>during the intervention/behavioral tasks with and without stimulation</time_frame>
    <description>heart rate variability will be measured in milliseconds.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physiological change - skin conductance</measure>
    <time_frame>during the intervention/behavioral tasks with and without stimulation</time_frame>
    <description>Skin conductance will be measured in microSiemens.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurophysiological activity</measure>
    <time_frame>during the intervention/behavioral tasks with and without stimulation</time_frame>
    <description>Neurophysiological activity will be measured in Hz</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Fear</condition>
  <condition>GAD</condition>
  <condition>Emotional Memory</condition>
  <condition>PTSD</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Deep brain stimulation will be used</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Has undergone acute depth or chronic responsive neurostimulation (RNS) electrode&#xD;
             placement&#xD;
&#xD;
          -  Willing to provide informed consent and participate in the study&#xD;
&#xD;
          -  Ability to read and write English fluently&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling to provide informed consent&#xD;
&#xD;
          -  Not a native English Speaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sonja Hiller</last_name>
    <phone>3107947517</phone>
    <email>suthanalab@mednet.ucla.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonja Hiller</last_name>
      <phone>310-794-7517</phone>
      <email>suthanalab@mednet.ucla.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Nanthia Suthana</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data collected for this research represent a valuable resource to the scientific community, and the PIs will make them accessible to others, while respecting the special needs for confidentiality. All data will be anonymized before being provided to the scientific community. Researchers can also request access to the data under collaborative and co-authorship agreements</ipd_description>
    <ipd_time_frame>All data will be provided by the time publication occurs or when the proposed funding period has ended.</ipd_time_frame>
    <ipd_access_criteria>Researchers can request access to the data under collaborative and coauthorship agreements prior to the end of the funding period or before publication.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

